Literature DB >> 11418598

Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences.

G Zimmer1, L Budz, G Herrler.   

Abstract

The F (fusion) protein of the respiratory syncytial viruses is synthesized as an inactive precursor F(0) that is proteolytically processed at the multibasic sequence KKRKRR(136) into the subunits F(1) and F(2) by the cellular protease furin. This maturation process is essential for the F protein to gain fusion competence. We observed that proteolytic cleavage additionally occurs at another basic motif, RARR(109), that also meets the requirements for furin recognition. Cleavage at both sites leads to the removal from the polypeptide chain of a glycosylated peptide of 27 amino acids. When the sequence RARR(109) was changed to NANR(109) or to RANN(109) by site-directed mutagenesis, cleavage by furin was completely prevented. Although the mutants were still processed at position Arg(136), they did not show any syncytia formation. Proteolytic cleavage of the modified motifs was achieved by treatment of transfected cells with trypsin converting the F mutants into their fusogenic forms. Our findings indicate that both furin consensus sequences have to be cleaved in order to activate the fusion protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418598     DOI: 10.1074/jbc.M102633200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture.

Authors:  Gert Zimmer; Karl-Klaus Conzelmann; Georg Herrler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 2.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

3.  C-terminal tyrosine residues modulate the fusion activity of the Hendra virus fusion protein.

Authors:  Andreea Popa; Cara Teresia Pager; Rebecca Ellis Dutch
Journal:  Biochemistry       Date:  2011-01-20       Impact factor: 3.162

4.  Engineering glycoprotein B of bovine herpesvirus 1 to function as transporter for secreted proteins: a new protein expression approach.

Authors:  Günther M Keil; Constanze Höhle; Katrin Giesow; Patricia König
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  A conserved region between the heptad repeats of paramyxovirus fusion proteins is critical for proper F protein folding.

Authors:  Amanda E Gardner; Kimberly L Martin; Rebecca E Dutch
Journal:  Biochemistry       Date:  2007-04-07       Impact factor: 3.162

6.  The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis.

Authors:  Julia Eckardt-Michel; Markus Lorek; Diane Baxmann; Thomas Grunwald; Günther M Keil; Gert Zimmer
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

7.  Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity.

Authors:  Joanna Rawling; Blanca García-Barreno; José A Melero
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

Review 8.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2.

Authors:  Yuta Shirogane; Makoto Takeda; Masaharu Iwasaki; Nobuhisa Ishiguro; Hiroki Takeuchi; Yuichiro Nakatsu; Maino Tahara; Hideaki Kikuta; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  Antigenicity and immunogenicity of unique prefusion-mimic F proteins presented on enveloped virus-like particles.

Authors:  Young-Man Kwon; Youri Lee; Ki Hye Kim; Yu Jin Jung; Zhuo Li; Subbiah Jeeva; Sujin Lee; Martin L Moore; Sang-Moo Kang
Journal:  Vaccine       Date:  2019-09-18       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.